Results 111 to 120 of about 1,084 (164)

A First-in-Human Study of ATM Inhibitor Lartesertib as Monotherapy in Patients with Advanced Solid Tumors. [PDF]

Clin Cancer Res
Siu LL, Yap TA, Genta S, Pennock G, Hicking C, Vagge DS, Mukker JK, Locatelli G, Tolcher AW.   +8 more
europepmc   +1 more source

Modulating Treatment Outcomes of Patients with Solid Tumors in Immunotherapy Trials: A Drug Interaction Analysis from a Phase I Unit. [PDF]

Cancer Res Commun
Braganca Xavier C, Andersen CR, Lim J, Slade JH, Bean SA, Kang L, Le H, Tsimberidou AM, Naing A, Hong DS, Dumbrava EE, Rodon Ahnert J, Pohlmann PR, Piha-Paul SA, Champiat S, Yap TA, Tang TY, Meric-Bernstam F, Fu S.   +18 more
europepmc   +1 more source

Testing new anticancer drugs before curative locoregional therapies: MDICT 2024 recommendations. [PDF]

ESMO Open
Methodology for the Development of Innovative Cancer Therapies Taskforce. Electronic address: lseymour@ctg.queensu.ca.
europepmc   +1 more source

Phase 1 first-in-human dose-escalation study of IMSA101, a novel cyclic di-nucleotide STING agonist, for patients with advanced solid tumor malignancies. [PDF]

J Immunother Cancer
Jacoby J, Mahalingam D, Alistar A, Garmey E, Kazmi S, Mooneyham T, Sun L, Yap TA, Vu P, Moser J.   +9 more
europepmc   +1 more source

Dynamic time warping network analysis of posttraumatic stress symptoms in Japanese first responders. [PDF]

Eur J Psychotraumatol
van der Does FHS, Kitano M, Nagamine M, Saito T, van der Wee NJA, Chiba T, Edo N, Vermetten E, Giltay EJ.   +8 more
europepmc   +1 more source

Lefitolimod in Combination with Ipilimumab in Patients with Advanced Solid Tumors: A Phase I Trial. [PDF]

J Immunother Precis Oncol
Nardo M, Gouda MA, Reilley MJ, Biter AB, Lim J, Bean SA, Nguyen LM, Bhosale PR, Ager CR, Couillault CA, Piha-Paul SA, Fu S, Tsimberidou AM, Yap TA, Naing A, Rodon J, Subbiah V, Karp DD, Curran MA, Hong DS.   +19 more
europepmc   +1 more source

Riesgos geológicos : terremotos

, 2008
Alonso Chaves, Francisco Manuel|||0000-0002-7079-2539, García Navarro, Encarnación|||0000-0001-6270-9101, Mantero Romero, Elena María   +2 more
openaire   +3 more sources

A structure-based tool to interpret the significance of kinase mutations in clinical next generation sequencing in cancer. [PDF]

Front Oncol
Rangarajan A, Sviezhentseva I, Gunderson E, Pikman Y, Jacobson MP, Apsel Winger B.   +5 more
europepmc   +1 more source